Form 4: Oscar Health CTO Sells Shares Under 10b5-1 Plan

Oscar Health's President of Technology & CTO, Mario Schlosser, sold 38,835 shares of Class A Common Stock for approximately $15.00 per share.

Summary

• Mario Schlosser, President of Technology & CTO and a Director of Oscar Health, Inc. (OSCR), reported a sale of company stock.
• The transaction involved the disposition of 38,835 shares of Class A Common Stock.
• The shares were sold on December 24, 2025, at a weighted average price of $15.00 per share, with individual transactions ranging from $15.00 to $15.01.
• Following this transaction, Schlosser beneficially owns 438,348 shares of Class A Common Stock.
• The sale was executed pursuant to a Rule 10b5-1 trading plan, which was adopted on September 23, 2025.

Sentiment

Score: 5

Explanation: The filing reports a routine insider stock sale executed under a pre-arranged 10b5-1 trading plan, which typically indicates a neutral sentiment as it's not a discretionary sale based on immediate market views.

Industry Context

This filing is a routine disclosure of an insider stock transaction, common across all industries for publicly traded companies. It reflects a pre-scheduled sale by a key executive and director, rather than a reaction to specific market or industry events.

Stakeholder Impact

• Shareholders: The sale represents a minor reduction in insider ownership, but its execution under a 10b5-1 plan suggests it is part of a pre-planned financial strategy rather than a signal of changing company outlook.

Key Dates

Keywords

Oscar Health, OSCR, Insider Trading, Form 4, Stock Sale, Mario Schlosser, 10b5-1 Plan, Technology CTO, Director